GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,453.00p
   
  • Change Today:
    -27.00p
  • 52 Week High: 1,812.50
  • 52 Week Low: 1,382.00
  • Currency: UK Pounds
  • Shares Issued: 4,145.09m
  • Volume: 7,705,179
  • Market Cap: £60,228m
  • RiskGrade: 129

Fundamentals - based on IFRS

  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Income Statement 30-Sep-23 30-Sep-22 30-Sep-21 30-Sep-20 30-Sep-19
Continuing Operations          
Revenue 8,147.00 7,829.00 6,627.00 8,646.00 9,385.00
Operating Profit/(Loss) 1,949.00 1,191.00 1,380.00 1,858.00 2,147.00
Profit Before Tax 1,791.00 1,012.00 1,192.00 1,671.00 1,951.00
Profit After Tax 1,534.00 779.00 946.00 1,430.00 1,716.00
Discontinued Operations          
Profit After Tax n/a 10,080.00 422.00 n/a n/a
PROFIT FOR THE PERIOD 1,534.00 10,859.00 1,368.00 1,430.00 1,716.00
           
Continuing EPS          
Earnings per Share - Basic 36.10p 18.80p 21.90p 25.00p 31.40p
Earnings per Share - Diluted 36.10p 18.80p 21.90p 24.70p 31.00p
Earnings per Share - Adjusted 50.40p 46.90p 113.90p 35.60p 38.60p
Continuing and Discontinued EPS          
Earnings per Share - Basic 36.10p 268.50p 29.20p 25.00p 31.40p
Earnings per Share - Diluted 36.10p 268.50p 29.20p 24.70p 31.00p
Earnings per Share - Adjusted 50.40p 46.90p 113.90p 35.60p 38.60p
Dividend per Share 14.00p 13.75p 23.75p 19.00p 19.00p
  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Balance Sheet 30-Sep-23 30-Sep-22 30-Sep-21 30-Sep-20 30-Sep-19
Total Non-Current Assets 39,622.00 40,064.00 60,435.00 61.05 62,255.00
Net Current Assets cn/a cn/a cn/a cn/a cn/a
Total Assets 60,862.00 60,313.00 78,689.00 80.93 83,245.00
Total Liabilities 48,243.00 51,597.00 56,941.00 60.30 65,185.00
Net Assets 12,619.00 8,716.00 21,748.00 20.62 18,060.00
           
Shareholders Funds 13,133.00 9,152.00 15,426.00 14.29 11,772.00
Minority Interests/Other Equity (514.00) (436.00) 6,322.00 6.34 6,288.00
Total Equity 12,619.00 8,716.00 21,748.00 20.62 18,060.00

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page